LMAT

LeMaitre Vascular Inc.

Price

$117.39

return (12m)

p/e

37.43

p/bv

5.74

DIVIDEND YIELD

0.89%

LMAT price

LeMaitre Vascular

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LMAT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals LMAT

Valuation

P/E

37.43

Sector -2.34

Industry 11.10

P/BV

5.74

Sector 2.17

Industry 3.33

P/Revenue (PSR)

9.11

Sector 2.00

Industry 1.71

EV/EBITDA

90.55

Sector -23.69

Industry -398.52

EV/EBIT

101.91

Sector -36.60

Industry -80.73

P/EBITDA

24.25

Sector -0.10

Industry 8.30

P/EBIT

27.22

Sector -2.08

Industry 5.69

P/Total Assets

3.71

Sector 1.18

Industry 1.57

P/Net Current Assets

9.16

Sector -10.91

Industry -3.38

P/Working Capital

5.25

Sector 0.09

Industry 10.51

EPS

2.71

Sector -0.93

Industry 1.10

BVPS

17.68

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

72.39%

Sector 44.28%

Industry 29.23%

EBITDA Margin

35.46%

Sector -291.45%

Industry 4.29%

EBIT Margin

31.51%

Sector -195.44%

Industry 1.44%

Operating Margin

28.50%

Sector -25.72%

Industry 2.16%

Net Profit Margins

24.35%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.11

Sector 0.12

Industry 0.27

Profitability

ROE

15.35%

Sector -34.71%

Industry 6.97%

ROA

9.91%

Sector -28.76%

Industry 2.97%

ROIC

24.83%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

0.89%

Sector -

Industry 0.01%

Payout

33.31%

Sector -

Industry 0.54%

Debt

Current Ratio

14.32

Sector 1.87

Industry 1.51

Net Debt / EBITDA

-8.41

Sector -2.18

Industry -1.68

Net Debt / EBIT

-9.46

Sector -0.74

Industry -7.00

Net Debt / Equity

-0.49

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.42

Sector -0.64

Industry 0.35

Equity/Assets

0.65

Sector 0.43

Industry 0.46

Liabilities/Assets

0.35

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

10.66%

Sector -

Industry -

5Y Earnings CAGR

18.33%

Sector -

Industry -

FAIR VALUE OF LeMaitre Vascular ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$117.39

Fair Value

$32.83

Upside Return potential.

-72.03%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LMAT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LMAT LeMaitre Vascular Inc.	$117.39	43.04%	0.89%	37.43	5.74	15.35%	24.35%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LMAT Historical Dividends

current DY: 0.89%

5-year average DY: 0.98%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/12/2026	03/26/2026	0.25000000
Dividends	11/20/2025	12/04/2025	0.20000000
Dividends	08/21/2025	09/04/2025	0.20000000
Dividends	05/15/2025	05/29/2025	0.20000000
Dividends	03/13/2025	03/27/2025	0.20000000
Dividends	11/21/2024	12/05/2024	0.16000000
Dividends	08/15/2024	08/29/2024	0.16000000
Dividends	05/16/2024	05/30/2024	0.16000000
Dividends	03/14/2024	03/28/2024	0.16000000
Dividends	11/16/2023	11/30/2023	0.14000000
Dividends	08/17/2023	08/31/2023	0.14000000
Dividends	05/17/2023	06/01/2023	0.14000000
Dividends	03/09/2023	03/23/2023	0.14000000
Dividends	11/17/2022	12/01/2022	0.12500000
Dividends	08/25/2022	09/08/2022	0.12500000
Dividends	05/17/2022	06/02/2022	0.12500000
Dividends	03/08/2022	03/24/2022	0.12500000
Dividends	11/19/2021	12/02/2021	0.11000000
Dividends	08/26/2021	09/09/2021	0.11000000
Dividends	05/19/2021	06/03/2021	0.11000000
Dividends	03/09/2021	03/25/2021	0.11000000
Dividends	11/19/2020	12/03/2020	0.09500000
Dividends	08/27/2020	09/10/2020	0.09500000
Dividends	05/20/2020	06/04/2020	0.09500000
Dividends	03/03/2020	03/19/2020	0.09500000
Dividends	11/20/2019	12/05/2019	0.08500000
Dividends	08/21/2019	09/05/2019	0.08500000
Dividends	05/22/2019	06/06/2019	0.08500000
Dividends	03/22/2019	04/05/2019	0.08500000
Dividends	11/20/2018	12/06/2018	0.07000000
Dividends	08/22/2018	09/06/2018	0.07000000
Dividends	05/22/2018	06/07/2018	0.07000000
Dividends	03/22/2018	04/05/2018	0.07000000
Dividends	11/22/2017	12/07/2017	0.05500000
Dividends	08/23/2017	09/07/2017	0.05500000
Dividends	05/24/2017	06/08/2017	0.05500000
Dividends	03/22/2017	04/06/2017	0.05500000
Dividends	11/21/2016	12/05/2016	0.04500000
Dividends	08/22/2016	09/06/2016	0.04500000
Dividends	05/25/2016	06/08/2016	0.04500000
Dividends	03/21/2016	04/04/2016	0.04500000
Dividends	11/20/2015	12/04/2015	0.04000000
Dividends	08/20/2015	09/03/2015	0.04000000
Dividends	05/22/2015	06/05/2015	0.04000000
Dividends	03/20/2015	04/03/2015	0.04000000
Dividends	11/20/2014	12/04/2014	0.03500000
Dividends	08/21/2014	09/04/2014	0.03500000
Dividends	05/22/2014	06/05/2014	0.03500000
Dividends	03/20/2014	04/03/2014	0.03500000
Dividends	11/20/2013	12/04/2013	0.03000000
Dividends	08/21/2013	09/04/2013	0.03000000
Dividends	05/22/2013	06/05/2013	0.03000000
Dividends	03/20/2013	04/03/2013	0.03000000
Dividends	11/20/2012	12/04/2012	0.02500000
Dividends	08/17/2012	09/04/2012	0.02500000
Dividends	05/18/2012	06/04/2012	0.02500000
Dividends	03/20/2012	04/03/2012	0.02500000
Dividends	11/23/2011	12/06/2011	0.02000000
Dividends	08/19/2011	09/06/2011	0.02000000
Dividends	05/20/2011	06/06/2011	0.02000000
Dividends	03/22/2011	04/05/2011	0.02000000

ABOUT LeMaitre Vascular

LeMaitre Vascular Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

43 years

Founded: 1983

2006

Time since IPO - 20 years

403

Employees

LeMaitre Vascular Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $2.34 billion, with shareholders equity totaling $406.62 million.

The company employs approximately 403 people and operates in the Saúde sector, within the Materiais e Equipamentos Médicos industry.

Over the past 12 months, LeMaitre Vascular Inc. reported $256.28 million in revenue, generating net income of $62.40 million.

Key financial metrics include a P/E ratio of 37.43, a price-to-book (P/B) ratio of 5.74, and a trailing twelve-month dividend yield of 0.89%.

The company trades under the ticker LMAT.

Market cap

$2.34 billion

Net worth

$406.62 million

$406,620,000.00

Assets

$629.53 million

$629,530,000.00

Total Shares Outstanding

23.00 million

23,000,000

Average Daily Trading Volume

$336.97 Thousand

$336,966.00

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

LMAT

LMAT revenue and profits

Financial Results LMAT

DRAG THE FRAME TO SEE MORE DATA

LMAT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56